Blueprint Medicines Corp (BPMC)
88.38
+2.29
(+2.66%)
USD |
NASDAQ |
Apr 17, 16:00
88.38
0.00 (0.00%)
Pre-Market: 20:00
Blueprint Medicines Max Drawdown (5Y): 69.50% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 69.50% |
| February 29, 2024 | 69.50% |
| January 31, 2024 | 69.50% |
| December 31, 2023 | 69.50% |
| November 30, 2023 | 69.50% |
| October 31, 2023 | 69.50% |
| September 30, 2023 | 69.50% |
| August 31, 2023 | 69.50% |
| July 31, 2023 | 69.50% |
| June 30, 2023 | 69.50% |
| May 31, 2023 | 69.50% |
| April 30, 2023 | 69.50% |
| March 31, 2023 | 69.50% |
| February 28, 2023 | 69.50% |
| January 31, 2023 | 67.01% |
| December 31, 2022 | 67.01% |
| November 30, 2022 | 67.01% |
| October 31, 2022 | 63.66% |
| September 30, 2022 | 63.66% |
| August 31, 2022 | 63.66% |
| July 31, 2022 | 63.66% |
| June 30, 2022 | 63.66% |
| May 31, 2022 | 58.35% |
| April 30, 2022 | 56.54% |
| March 31, 2022 | 56.54% |
| Date | Value |
|---|---|
| February 28, 2022 | 55.74% |
| January 31, 2022 | 55.74% |
| December 31, 2021 | 55.74% |
| November 30, 2021 | 55.74% |
| October 31, 2021 | 55.74% |
| September 30, 2021 | 55.74% |
| August 31, 2021 | 55.74% |
| July 31, 2021 | 55.74% |
| June 30, 2021 | 55.74% |
| May 31, 2021 | 55.74% |
| April 30, 2021 | 55.74% |
| March 31, 2021 | 55.74% |
| February 28, 2021 | 62.00% |
| January 31, 2021 | 62.00% |
| December 31, 2020 | 62.00% |
| November 30, 2020 | 62.86% |
| October 31, 2020 | 62.86% |
| September 30, 2020 | 62.86% |
| August 31, 2020 | 62.86% |
| July 31, 2020 | 62.86% |
| June 30, 2020 | 62.86% |
| May 31, 2020 | 62.86% |
| April 30, 2020 | 62.86% |
| March 31, 2020 | 62.86% |
| February 29, 2020 | 62.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
55.74%
Minimum
Mar 2021
69.50%
Maximum
Feb 2023
62.93%
Average
62.86%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 54.98% |
| Apellis Pharmaceuticals Inc | 74.65% |
| Ionis Pharmaceuticals Inc | 70.27% |
| Madrigal Pharmaceuticals Inc | 82.20% |
| Sarepta Therapeutics Inc | 64.93% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.829 |
| Beta (5Y) | 0.6348 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 51.66% |
| Historical Sharpe Ratio (5Y) | 0.0282 |
| Historical Sortino (5Y) | 0.0515 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.27% |